Department of Ophthalmology, Siena University, Siena, Italy.
Acta Ophthalmol. 2012 May;90(3):259-65. doi: 10.1111/j.1755-3768.2010.01890.x. Epub 2010 Apr 23.
To investigate the correlations between corneal structural modifications assessed by in vivo corneal confocal microscopy with visual function [uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA)] and morphological data (corneal topography, pachymetry, elevation analysis) after riboflavin UV A corneal collagen cross-linking (CXL) for the stabilization of progressive keratoconus.
Forty-four eyes with progressive keratoconus were enrolled in the Siena Eye Cross Study (prospective nonrandomized phase II open trial). All eyes underwent Riboflavin UV A CXL. Preoperative and postoperative evaluation comprised: UCVA, BSCVA, optical pachymetry (Visante OCT, Zeiss, Germany), corneal topography (CSO, Florence, Italy) and tomography (Orbscan IIz; B&L, Rochester, NY, USA) and in vivo confocal microscopy (Heidelberg Retina Tomograph II; Rostock, Heidelberg Gmbh, Germany). Examinations were performed preoperatively 6 months and one day before treatment and at 1, 3, 6 and 12 months of follow-up.
In vivo corneal confocal microscopy showed time-dependent postoperative epithelial and stromal modifications after cross-linking. Epithelial thinning associated with stromal oedema and keratocytes apoptosis explained initial tendency towards slightly reduced VA and more glare one month postoperatively in 70% of eyes. Furthermore, a statistically not significant early worsening of topographic mean K values was observed. Orbscan II analysis significantly underestimated pachymetric values after treatment. Pachymetric underestimation was rectified by high-resolution optical pachymetry provided by the Visante OCT system. After the third post-CXL month, epithelial thickening, disappearance of oedema and new collagen compaction recorded by in vivo corneal confocal microscopy explained the improvements in visual performance during the follow-up. Changes in stromal reflectivity and collagen compaction observed by in vivo confocal microscopy were associated with corneal flattening and reduction in anterior elevation values recorded by differential topographic analysis.
Corneal structural changes assessed by in vivo corneal confocal microscopy demonstrated significant correlations with visual function (UCVA and BSCVA) and morphological (corneal topography, pachymetry, elevation analysis) findings recorded after riboflavin-UV A-induced CXL.
通过活体角膜共聚焦显微镜评估的角膜结构改变与视觉功能[未矫正视力(UCVA)、最佳矫正视力(BSCVA)]以及形态学数据(角膜地形图、角膜厚度、高度分析)之间的相关性,以评估核黄素紫外线 A 角膜胶原交联(CXL)治疗进展性圆锥角膜的稳定性。
44 只进展性圆锥角膜眼纳入锡耶纳眼交叉研究(前瞻性非随机二期开放试验)。所有眼均接受核黄素紫外线 A CXL 治疗。术前和术后评估包括:UCVA、BSCVA、光学角膜厚度计(Visante OCT,蔡司,德国)、角膜地形图(CSO,佛罗伦萨,意大利)和断层扫描(Orbscan IIz;B&L,罗切斯特,纽约,美国)以及活体角膜共聚焦显微镜(Heidelberg Retina Tomograph II;Rostock,Heidelberg GmbH,德国)。术前 6 个月、治疗前 1 天以及术后 1、3、6 和 12 个月进行检查。
活体角膜共聚焦显微镜显示交联术后上皮和基质的时间依赖性改变。上皮变薄伴基质水肿和角膜细胞凋亡导致术后 1 个月 70%的眼 VA 略有下降和眩光增加。此外,还观察到早期平均 K 值的统计学上无显著恶化。Orbscan II 分析在治疗后显著低估了角膜厚度值。Visante OCT 系统提供的高分辨率光学角膜厚度计纠正了治疗后的角膜厚度低估。在 CXL 后第三个月,活体角膜共聚焦显微镜记录的上皮增厚、水肿消失和新胶原压缩解释了随访期间视力的改善。活体角膜共聚焦显微镜观察到的基质反射率和胶原压缩变化与差分地形图分析记录的角膜变平以及前突值减少相关。
活体角膜共聚焦显微镜评估的角膜结构变化与视觉功能(UCVA 和 BSCVA)和形态学(角膜地形图、角膜厚度、高度分析)发现之间存在显著相关性,这些发现是在核黄素紫外线 A 诱导的 CXL 后记录的。